Immune response from STRIDE, a randomized, Phase II, open-label study of sipuleucel-T (sip-T) with concurrent vs sequential enzalutamide (enz) administration in metastatic castration-resistant prostate cancer (mCRPC). (4th November 2015)

Record Type:: Journal Article
Title:: Immune response from STRIDE, a randomized, Phase II, open-label study of sipuleucel-T (sip-T) with concurrent vs sequential enzalutamide (enz) administration in metastatic castration-resistant prostate cancer (mCRPC). (4th November 2015)
Main Title:: Immune response from STRIDE, a randomized, Phase II, open-label study of sipuleucel-T (sip-T) with concurrent vs sequential enzalutamide (enz) administration in metastatic castration-resistant prostate cancer (mCRPC)
Authors:: Drake, Charles G
Quinn, David
Dreicer, Robert
Antonarakis, Emmanuel
Shore, Neal
Corman, John
Concepcion, Raoul
Pieczonka, Christopher
Campogan, Dwayne
Fan, Li-Qun
Chang, Nancy
Sheikh, Nadeem
Petrylak, Daniel
Abstract:
Is Part Of:: Journal for immunotherapy of cancer. Volume 3(2015)Supplement 2
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 3(2015)Supplement 2
Issue Display:: Volume 3, Issue 2 (2015)
Year:: 2015
Volume:: 3
Issue:: 2
Issue Sort Value:: 2015-0003-0002-0000
Page Start:
Page End:
Publication Date:: 2015-11-04
Subjects:: Androgen Receptor -- Humoral Immune Response -- Humoral Response -- Enzalutamide -- Cell Proliferative Response
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:: http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:: 10.1186/2051-1426-3-S2-P145 ↗
Languages:: English
ISSNs:: 2051-1426
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 19196.xml